Related Experiment Video
Updated: Nov 14, 2025
09:30
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
Published on: October 4, 2016
22.6K
Is tDCS a potential first line treatment for major depression?
Rachel Woodham1, Rachael M Rimmer1, Julian Mutz2
1School of Psychology, University of East London, London, UK.
International Review of Psychiatry (Abingdon, England)
|March 12, 2021
Summary
Transcranial direct current stimulation (tDCS) shows promise for major depression treatment, particularly in early episodes. Further trials are needed to confirm the efficacy and feasibility of home-based tDCS.
Area of Science:
- Neuroscience
- Psychiatry
- Neuromodulation
Background:
- Major depression is a leading cause of disability worldwide.
- Current treatments have limitations in efficacy and side effects.
- Novel therapeutic approaches are needed for major depressive disorder.
Purpose of the Study:
- To evaluate transcranial direct current stimulation (tDCS) as a treatment for major depression.
- To explore the mechanisms underlying tDCS effects in depression.
- To assess the potential for home-based tDCS treatment.
Main Methods:
- Non-invasive brain stimulation using weak direct current (0.5-2 mA) via scalp electrodes.
- Anodal stimulation targeting the left dorsolateral prefrontal cortex is common for depression.
- Comparison of active tDCS against placebo sham-controlled conditions.
Main Results:
- Active tDCS demonstrated greater clinical response, remission rates, and symptom improvement than sham tDCS.
- Largest effects observed in first-episode and recurrent major depression.
- Minimal effects noted in treatment-resistant depression.
- Proposed mechanisms involve neuroplasticity and altered prefrontal-amygdala connectivity.
- Cognitive impairments may also improve with tDCS.
Conclusions:
- tDCS is a viable treatment option for major depression, potentially as a first-line therapy.
- Neuroplasticity and improved cognitive control are potential mechanisms.
- Home-based tDCS requires further investigation for efficacy and acceptability.
- Future clinical trials are essential to establish home-based tDCS protocols.
Related Concept Videos
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
934
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
934
01:23Antidepressant Drugs: MAOIs and Other Agents
558
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
558
01:25Antidepressant Drugs: Overview
1.0K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.0K
01:30Electroconvulsive Therapy
379
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
379
01:25Cognitive Therapy
609
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
609
01:27Depressive Disorders: MDD and Dysthymia
319
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
319